Pfizer PFE Restructuring Reserve
Discontinued — last reported Q3 '25
Restructuring Reserve at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Pfizer in its filing.
Tagged under the XBRL concept us-gaap:RestructuringReserve.
The official record: Pfizer’s 10-Q, filed November 4, 2025, on SEC EDGAR. View the filing →
Ask your AI about Pfizer's restructuring reserve.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Pfizer's restructuring reserve?
- Pfizer (PFE) reported restructuring reserve of $1.84B in Q3 2025.
- How has Pfizer's restructuring reserve changed year-over-year?
- Pfizer's restructuring reserve decreased by 13.9% year-over-year, from $2.13B to $1.84B.
- What is the long-term trend for Pfizer's restructuring reserve?
- Over 4 years (2020 to 2024), Pfizer's restructuring reserve has grown at a 27.7% compound annual growth rate (CAGR), from $798M to $2.12B.
- What does restructuring reserve mean?
- This represents the estimated liability for costs associated with formal restructuring plans, such as severance, facility closures, or asset impairments. It reflects management's commitment to operational efficiency and strategic realignment. These reserves are drawn down as the restructuring activities are executed.